Eradication rate of Helicobacter pylori EDITOR,-The paper by Moshkowitz et al (Gut 1995; 36: 845-7) suggesting that the pretreatment 14C-urea breath test results are related to the outcome of triple therapy consisting of colloidal bismuth, metronidazole, and amoxicillin raises several points. Unfortunately, the authors did not exclude confounding variables such as compliance, metronidazole resistance, smoking, age, and pretreatment with antibiotics and antisecretory drugs, respectively, which may also have an important effect on the outcome of eradication therapy. Another weakness of this particular study is that the authors did not prove the correlation between the urea breath test and histology, although biopsy specimens were taken for histological examination in all patients. On the basis of previously published correlation studies between breath test results and histology, the authors concluded that it is the density of H pylori that predicts the outcome of eradication therapy. We cannot agree with this conclusion.
Firstly, the urea breath test, as an indirect measure, may reflect the total gastric urease activity, however, urease activities may vary considerably between H pylori strains.' Thus, in clinical practice the accurate prediction of the H pylori density by non-invasive breath tests will in all likelihood be the exception rather than the rule.
Several studies have shown that a significant correlation does exist between urea breath test results and both the density of H pylori infection and the severity of gastritis. But what does a significant correlation imply clinically? Because of the high sensibility of statistical tests in correlation analyses, rather weak correlations may result in statistical significance. It is, however, the determination coefficient (squared correlation coefficient) that reflects the proportion of results that would have been predicted properly when one of two correlated variables is known. For example, we have found highly significant correlations (p<0-000 1) between the '3C02 excess after intake of labelled urea and the histologically visible degree of H pylori colonisation (r=0-81), the degree (r=0-72) and the activity of gastritis (r=0-69) as well.2 These correlations showed that the histological findings would have been predicted properly in 66%, 52%, and 48% of cases, respectively, which is of course clinically not very useful. It should also be mentioned that some of the studies quoted by Moshkowitz were published only as abstracts, which do not permit the estimation of the clinical relevance of the correlations, because the correlation coefficients are not given.
Previous studies have suggested that the density of H pylori determines both the grade and the activity of gastritis.3 4 Recent studies have also shown that the severity of gastritis predicts the success of eradication therapy with triple therapy5 as well as dual therapy consisting of omeprazole and amoxicillin6 in the sense that a more severe gastritis is associated with a higher likelihood of eradication success. Grade and activity of gastritis reflect the specific and non-specific immune response of the host to the infection with H pylon. Although scientifically unconfirmed up to now, it seems to be plausible that comparable to other infectious diseases it is the immune response that facilitates eradication of H pylon whatever treatment is used. Provided the urea breath test used by Moshkowitz et al does actually reflect the H pylori density and thus in turn the severity of gastritis, the finding of a higher eradication rate in patients with lower urea breath test values is in apparent contradiction to the studies quoted above.
In EDITOR,-We would like to comment on the article by Moshkowitz et al on the association between H pylon colonisation density and eradication rate with a triple therapy (Gut 1995; 36: 845-7) . We agree that the bacterial density in the stomach is of considerable predictive value for eradication of the organism with triple therapy. We would suggest, however, that the treatment failure in the study was actually caused by metronidazole resistance, mainly acquired resistance that developed during the treatment. In this study, unfortunately, the authors did not test the isolates for sensitivity to metronidazole, either before, or after the treatment. The authors referred to one of their previous studies showing a resistance rate of 6%, but the sample number was too small (only 18) to predict the prevalence of metronidazole resistant strains in their population. Moreover, even if this result were accurate, it could not exclude the possibility of acquired resistance in the strains that were not eradicated.
In an in vitro study, Berger et al assessed the effect of inoculum size on the susceptibility of 15 clinical isolates of H pylori to six antimicrobial agents by an agar dilution method. A considerable inoculum effect was found with metronidazole; the mean minimal inhibitory concentrations of the drug increased 21 2-fold (from 0 11 to 2-33 mg/l) as the inoculum size progressed from 103 to 107 cfu/spot. ' Haas et al showed that the frequencies of spontaneous resistance for four isolates of H pylori to seven different classes of antimicrobial agents varied from <4-2X 10-9 to 5X 10-5. The highest rate of spontaneous resistance was to metronidazole, being from <3-5X 10-8 to 5X10-5.2 Furthermore, resistant mutants of H pylori to metronidazole, ciprofloxacin, and tobramycin could be easily selected in vitro, using the serial passage technique.2
In the authors' study, it is not surprising that they saw a poor eradication rate (64.4%) with their triple regimen, which incorporated a low daily dose of metronidazole (250 mg twice daily for two weeks). This dose was much lower than that in the regimens recommended by the Working Party (400 mg three times day for two weeks)3 and those currently used by others.4 5 Eradication rates of 72-95% were achieved with those regimens.3-5
The 'inoculum effect' and spontaneous resistance among H pylori strains in the stomach may account for the low eradication rate obtained in the study. It has been shown that, in untreated patients with duodenal ulcer or gastritis, the bacterial density of H pylon infection in the gastric antrum and body is as high as 1-3X 108 to 6-9X 108 cfu/g of mucosal tissue.6 After ineffective antimicrobial therapy, H pylori can still be cultured from antral biopsy specimens at concentrations of
